Dr. Martens PLC (STU:3U2)

€ 0.89 0 (0%) Market Cap: 850.28 Mil Enterprise Value: 1.28 Bil PE Ratio: 25.57 PB Ratio: 2.13 GF Score: 62/100

Half Year 2025 Dr Martens PLC Earnings Call Transcript
Nov 28, 2024

€0.77 (+11.59%)

Earnings
Full Year 2024 Dr Martens PLC Earnings Presentation Transcript
May 30, 2024
Q3 2023 Dr Martens PLC Trading Statement Call Transcript
Jan 25, 2024
Half Year 2024 Dr Martens PLC Earnings Call Transcript
Nov 30, 2023

€0.965 (-25.77%)

Earnings
Full Year 2023 Dr Martens PLC Earnings Call Transcript
Jun 01, 2023

€1.64 (-6.82%)

Earnings
Q4 2023 Dr Martens PLC Trading Statement Call Transcript
Apr 14, 2023
Q3 2022 Dr Martens PLC Trading Statement Call Transcript
Jan 19, 2023
Half Year 2023 Dr Martens PLC Earnings Call Transcript
Nov 24, 2022

€3.24 (-1.82%)

Earnings
Full Year 2022 Dr Martens PLC Earnings Call Transcript
Jun 01, 2022

€3.04 (+18.75%)

Earnings
Q3 2022 Dr Martens PLC Trading Statement Call Transcript
Jan 27, 2022
Half Year 2022 Dr Martens PLC Earnings Presentation Transcript
Dec 09, 2021
Full Year 2021 Dr Martens PLC Earnings Presentation Transcript
Jun 17, 2021

Full Year 2022 Dr Martens PLC Earnings Call Transcript

Jun 01, 2022 / 08:30AM GMT

Release Date Price: €3.04 (+18.75%)

Transcript

Kenneth Wilson

Dr. Martens plc - CEO & Director

Okay. Good morning, everyone, and thank you for joining us today both in person. It's great to have an in-person audience again and on the webcast. I'm Kenny Wilson, the CEO of Dr. Martens, and I'll be joined today by Jon Mortimore, our Chief Financial Officer. Also, in the audience, we have Paul Mason, our Chairman; and Emily Reichwald, our Chief Legal Counsel.

Iâm sure that most of you know Bethany, our IR Director. Well, Bethany is off on maternity leave in just a few weeks. So I'm also pleased to welcome Mark Blythman today as our interim Head of Investor Relations. And if you've got any questions in the weeks ahead, then please reach out to Mark.

So our agenda for today, well, I'm going to talk us through the key takeaways for our financial year '22, and then Jon is going to pick up and take us through a detailed review of our financial performance. And then I'll come back to talk about our strategic performance, but probably more importantly, why I feel really confident about financial year '23, the year ahead and even more

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.